Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2009 2
2016 1
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Genotyping, sequencing and analysis of 140,000 adults from Mexico City.
Ziyatdinov A, Torres J, Alegre-Díaz J, Backman J, Mbatchou J, Turner M, Gaynor SM, Joseph T, Zou Y, Liu D, Wade R, Staples J, Panea R, Popov A, Bai X, Balasubramanian S, Habegger L, Lanche R, Lopez A, Maxwell E, Jones M, García-Ortiz H, Ramirez-Reyes R, Santacruz-Benítez R, Nag A, Smith KR, Damask A, Lin N, Paulding C, Reppell M, Zöllner S, Jorgenson E, Salerno W, Petrovski S, Overton J, Reid J, Thornton TA, Abecasis G, Berumen J, Orozco-Orozco L, Collins R; Regeneron Genetics Center; Mexico City Prospective Study; Baras A, Hill MR, Emberson JR, Marchini J, Kuri-Morales P, Tapia-Conyer R. Ziyatdinov A, et al. Nature. 2023 Oct;622(7984):784-793. doi: 10.1038/s41586-023-06595-3. Epub 2023 Oct 11. Nature. 2023. PMID: 37821707 Free PMC article.
Impact of Mobile Technologies on Cervical Cancer Screening Practices in Lagos, Nigeria (mHealth-Cervix): A Randomized Controlled Trial.
Okunade KS, Soibi-Harry A, John-Olabode S, Adejimi AA, Allsop MJ, Onyeka TC, Akaba GO, Oshodi YA, Salako O, Ugwu AO, Adefemi A, Anorlu RI, Berek JS. Okunade KS, et al. JCO Glob Oncol. 2021 Aug;7:1418-1425. doi: 10.1200/GO.21.00258. JCO Glob Oncol. 2021. PMID: 34554814 Free PMC article. Clinical Trial.
PURPOSE: We assessed the impact of mHealth on Pap test screening uptake and also determined the factors that affect screening uptake among women in Lagos, Nigeria. ...Following adjustment in the final multivariate model, level of income (odds ratio [OR] = 5.13, 95% CI, 1.5 …
PURPOSE: We assessed the impact of mHealth on Pap test screening uptake and also determined the factors that affect screening uptake …
Early non-invasive diagnosis of cervical cancer: beyond Pap smears and human papilloma virus (HPV) testing.
Mathur SP, Mathur RS, Creasman WT, Underwood PB, Kohler M. Mathur SP, et al. Cancer Biomark. 2005;1(2-3):183-91. doi: 10.3233/cbm-2005-12-306. Cancer Biomark. 2005. PMID: 17192039
Cervical cancer is a major gynecologic malignancy around the world. However, current diagnostic methods such as Pap smear and human papilloma virus (HPV) testing are insufficient for an early diagnosis of cervical cancer, follow-up on therapy efficacy or to identify the wo …
Cervical cancer is a major gynecologic malignancy around the world. However, current diagnostic methods such as Pap smear and human p …
Prioritizing US Cervical Cancer Prevention With Results From a Geospatial Model.
Kish JK, Rolin AI, Zou Z, Cucinelli JE, Tatalovich Z, Saraiya M, Altekruse SF. Kish JK, et al. J Glob Oncol. 2016 Oct;2(5):275-283. doi: 10.1200/JGO.2015.001677. J Glob Oncol. 2016. PMID: 28413829 Free PMC article.
Rates for health service areas were also modeled by ethnicity. State-level incidence was mapped together with Papanicolaou (Pap) screening, past 3 years (women 18 years old), and three-dose human papillomavirus (HPV) vaccine coverage (girls 13 to 17 years old) to identify …
Rates for health service areas were also modeled by ethnicity. State-level incidence was mapped together with Papanicolaou (Pap) scre …
Caring for women with abnormal papanicolaou tests during pregnancy.
Bond S. Bond S. J Midwifery Womens Health. 2009 May-Jun;54(3):201-10. doi: 10.1016/j.jmwh.2009.01.004. J Midwifery Womens Health. 2009. PMID: 19410212
The Papanicolaou (Pap) test is one of the best screening tests available for cancer detection and has achieved widespread acceptance among women. ...Postponing colposcopy in pregnant, reproductive-age women with minor Pap changes until after delivery is now acceptab …
The Papanicolaou (Pap) test is one of the best screening tests available for cancer detection and has achieved widespread acceptance …
Serum vascular endothelial growth factor C (VEGF-C) as a specific biomarker for advanced cervical cancer: Relationship to insulin-like growth factor II (IGF-II), IGF binding protein 3 (IGF-BP3) and VEGF-A [corrected].
Mathur SP, Mathur RS, Gray EA, Lane D, Underwood PG, Kohler M, Creasman WT. Mathur SP, et al. Gynecol Oncol. 2005 Sep;98(3):467-83. doi: 10.1016/j.ygyno.2005.05.003. Gynecol Oncol. 2005. PMID: 15982726
MATERIAL AND METHODS: (a) Serum levels of IGF-II, IGF-BP3, VEGF-A [corrected] (VEGF(165)) and VEGF-C (ELISA kits) were determined in: 82 controls with normal Pap smears; 29 women with atypical squamous cells of undetermined significance (ASCUS) and normal cervical biopsy; …
MATERIAL AND METHODS: (a) Serum levels of IGF-II, IGF-BP3, VEGF-A [corrected] (VEGF(165)) and VEGF-C (ELISA kits) were determined in: 82 con …